Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
- PMID: 26005969
- PMCID: PMC4752091
- DOI: 10.1590/S1677-5538.IBJU.2015.02.14
Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats
Abstract
Introduction: Ureteral obstruction is a common pathology and caused kidney fibrosis and dysfunction at late period. In this present, we investigated the antifibrotic and antiinflammatory effects of montelukast which is cysteinyl leukotriene receptor antagonist, on kidney damage after unilateral ureteral obstruction(UUO) in rats.
Materials and methods: 32 rats divided four groups. Group 1 was control, group 2 was sham, group 3 was rats with UUO and group 4 was rats with UUO which were given montelukast sodium (oral 10 mg/kg/day). After 14 days, rats were killed and their kidneys were taken and blood analysis was performed. Tubular necrosis, mononuclear cell infiltration and interstitial fibrosis scoring were determined histopathologically in a part of kidneys; nitric oxide(NO), malondialdehyde(MDA) and reduced glutathione(GSH) levels were determined in the other part of kidneys. Urea-creatinine levels were investigated at blood analysis. Statistical analyses were made by the Chi-square test and one-way analysis of variance (ANOVA).
Results: There was no difference significantly for urea-creatinine levels between groups. Pathologically, there was serious tubular necrosis and fibrosis in group 3 and there was significantly decreasing for tubular necrosis and fibrosis in group 4(p<0.005). Also, there was significantly increasing for NO and MDA levels; decreasing for GSH levels in group 3 compared the other groups(p<0.005).
Conclusion: We can say that montelukast prevent kidney damage with antioxidant effect, independently of NO.
Conflict of interest statement
CONFLICT OF INTEREST: None declared.
Figures



Similar articles
-
Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction.Int Braz J Urol. 2015 Nov-Dec;41(6):1185-93. doi: 10.1590/S1677-5538.IBJU.2014.0090. Int Braz J Urol. 2015. PMID: 26742979 Free PMC article.
-
Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.Ren Fail. 2013;35(3):403-10. doi: 10.3109/0886022X.2012.761040. Epub 2013 Jan 24. Ren Fail. 2013. PMID: 23342977
-
Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.Eur J Pharmacol. 2007 Feb 14;557(1):69-75. doi: 10.1016/j.ejphar.2006.11.009. Epub 2006 Nov 10. Eur J Pharmacol. 2007. PMID: 17173892
-
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Eur J Clin Pharmacol. 2017 Jul;73(7):799-809. doi: 10.1007/s00228-017-2242-2. Epub 2017 Apr 4. Eur J Clin Pharmacol. 2017. PMID: 28374082 Review.
-
[The role of leukotrienes in inflammation and leukotriene inhibitors].Pol Merkur Lekarski. 1999 Sep;7(39):85-93. Pol Merkur Lekarski. 1999. PMID: 10598480 Review. Polish.
Cited by
-
Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin-induced pulmonary fibrosis.Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Sep 16;26(4):588-597. doi: 10.5606/tgkdc.dergisi.2019.15149. eCollection 2018 Oct. Turk Gogus Kalp Damar Cerrahisi Derg. 2018. PMID: 32082801 Free PMC article.
-
Ameliorating Effect of Pentadecapeptide Derived from Cyclina sinensis on Cyclophosphamide-Induced Nephrotoxicity.Mar Drugs. 2020 Sep 9;18(9):462. doi: 10.3390/md18090462. Mar Drugs. 2020. PMID: 32916975 Free PMC article.
-
Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways.Inflammopharmacology. 2024 Feb;32(1):495-508. doi: 10.1007/s10787-023-01301-1. Epub 2023 Jul 27. Inflammopharmacology. 2024. PMID: 37498374 Free PMC article.
-
Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.Br J Pharmacol. 2017 Oct;174(19):3346-3358. doi: 10.1111/bph.13953. Epub 2017 Aug 23. Br J Pharmacol. 2017. PMID: 28718891 Free PMC article.
-
The renoprotective potential of montelukast: a scoping review.Ann Med Surg (Lond). 2024 Apr 22;86(6):3568-3576. doi: 10.1097/MS9.0000000000002085. eCollection 2024 Jun. Ann Med Surg (Lond). 2024. PMID: 38846849 Free PMC article.
References
-
- Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M. Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:277–283. - PubMed
-
- Vaughan ED, Jr, Sorenson EJ, Gillenwater JY. The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest Urol. 1970;8:78–90. - PubMed
-
- Schreiner GF, Harris KP, Purkerson ML, Klahr S. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int. 1988;34:487–493. - PubMed
-
- Ricardo SD, Ding G, Eufemio M, Diamond JR. Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol. 1997;272:F789–F798. - PubMed
-
- Saborio P, Krieg RJ, Jr, Kuemmerle NB, Norkus EP, Schwartz CC, Chan JC. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr Nephrol. 2000;14:740–746. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources